T1	Intervention 0 71	Mexiletine for HIV-infected patients with painful peripheral neuropathy
T2	Intervention 417 651	mexiletine in HIV-related PPN were assessed in 22 patients who were randomized to receive mexiletine (maximum dose, 600 mg/day) or placebo for 6 weeks, followed by the alternative intervention for 6 weeks after a 1-week washout period
